Literature DB >> 28210938

Cardiac hypertrophy in Cushing's syndrome: if not hypertension then what?

D A Vassiliadi1, S Tsagarakis2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28210938     DOI： 10.1007/s12020-017-1260-2

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  17 in total

Review 1.  Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.

Authors:  R N Clayton; D Raskauskiene; R C Reulen; P W Jones
Journal:  J Clin Endocrinol Metab       Date:  2010-12-30       Impact factor: 5.958

2.  Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome.

Authors:  Kai Hang Yiu; Nina Ajmone Marsan; Victoria Delgado; Nienke R Biermasz; Eduard R Holman; Johannes W A Smit; Richard A Feelders; Jeroen J Bax; Alberto M Pereira
Journal:  Eur J Endocrinol       Date:  2011-10-17       Impact factor: 6.664

Review 3.  Glucocorticoids and cardiovascular disease.

Authors:  Brian R Walker
Journal:  Eur J Endocrinol       Date:  2007-11       Impact factor: 6.664

4.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

Review 5.  Management of endocrine disease: Mortality remains increased in Cushing's disease despite biochemical remission: a systematic review and meta-analysis.

Authors:  Femke M van Haalen; Leonie H A Broersen; Jens O Jorgensen; Alberto M Pereira; Olaf M Dekkers
Journal:  Eur J Endocrinol       Date:  2015-04       Impact factor: 6.664

6.  Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension.

Authors:  Yuan-Yuan Kang; Yan Li; Qi-Fang Huang; Jie Song; Xiao-Li Shan; Yu Dou; Xin-Juan Xu; Shou-Hong Chen; Ji-Guang Wang
Journal:  J Hypertens       Date:  2015-08       Impact factor: 4.844

7.  Left ventricular geometry and 24-h blood pressure profile in Cushing's syndrome.

Authors:  Eleonora Avenatti; Andrea Rebellato; Andrea Iannaccone; Marialberta Battocchio; Francesca Dassie; Franco Veglio; Alberto Milan; Francesco Fallo
Journal:  Endocrine       Date:  2016-05-14       Impact factor: 3.633

8.  Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.

Authors:  P Verdecchia; G Schillaci; M Guerrieri; C Gatteschi; G Benemio; F Boldrini; C Porcellati
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

9.  Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome.

Authors:  Alberto M Pereira; Victoria Delgado; Johannes A Romijn; Johannes W A Smit; Jeroen J Bax; Richard A Feelders
Journal:  Eur J Endocrinol       Date:  2009-11-23       Impact factor: 6.664

10.  Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study.

Authors:  Richard N Clayton; Peter W Jones; Raoul C Reulen; Paul M Stewart; Zaki K Hassan-Smith; Georgia Ntali; Niki Karavitaki; Olaf M Dekkers; Alberto M Pereira; Mark Bolland; Ian Holdaway; Jorgen Lindholm
Journal:  Lancet Diabetes Endocrinol       Date:  2016-06-02       Impact factor: 32.069
View more
  3 in total

1.  The influence of TNF-α on the expression profile of key enzymes of steroidogenesis in H295R cells.

Authors:  Beniamin Grabarek; Krzysztof Cholewa; Jolanta Lodowska
Journal:  Postepy Dermatol Alergol       Date:  2021-07-26       Impact factor: 1.837

2.  The SRSF4-GAS5-Glucocorticoid Receptor Axis Regulates Ventricular Hypertrophy.

Authors:  Javier Larrasa-Alonso; María Villalba-Orero; Carlos Martí-Gómez; Paula Ortiz-Sánchez; Marina M López-Olañeta; M Ascensión Rey-Martín; Fátima Sánchez-Cabo; François McNicoll; Michaela Müller-McNicoll; Pablo García-Pavía; Enrique Lara-Pezzi
Journal:  Circ Res       Date:  2021-08-02       Impact factor: 23.213

3.  Cushing Syndrome Associated Myopathy: It Is Time for a Change.

Authors:  Martin Reincke
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.